BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15859134)

  • 21. Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.
    Schiffmann R; Floeter MK; Dambrosia JM; Gupta S; Moore DF; Sharabi Y; Khurana RK; Brady RO
    Muscle Nerve; 2003 Dec; 28(6):703-10. PubMed ID: 14639584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiological follow-up in patients with Fabry disease].
    Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
    G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fabry disease: diagnostic due of substitutive enzyme-therapy].
    Barbey F; Widmer U; Burnier M; Lidove O
    Rev Med Suisse Romande; 2002 Sep; 122(9):449-53. PubMed ID: 12422475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of patients with Fabry disease in Argentina].
    AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
    Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel alpha-galactosidase a mutant (M42L) identified in a renal variant of Fabry disease.
    Rosenthal D; Lien YH; Lager D; Lai LW; Shang S; Leung N; Fervenza FC
    Am J Kidney Dis; 2004 Nov; 44(5):e85-9. PubMed ID: 15492942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Early diagnosis of Fabry disease in children].
    Genoni G; Demarchi I; Bellone S; Petri A; Settanni F; Dondi E; Negro M; Cortese L; Prodam F; Bona G
    Minerva Pediatr; 2011 Oct; 63(5):425-30. PubMed ID: 21946453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fabry disease: cardiac manifestations and therapeutic options.
    Pierre-Louis B; Kumar A; Frishman WH
    Cardiol Rev; 2009; 17(1):31-5. PubMed ID: 19092368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal involvement in Anderson-Fabry disease.
    Sessa A; Meroni M; Battini G; Righetti M; Maglio A; Tosoni A; Nebuloni M; Vago G; Giordano F
    J Nephrol; 2003; 16(2):310-3. PubMed ID: 12774774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fabry disease.
    Germain DP
    Orphanet J Rare Dis; 2010 Nov; 5():30. PubMed ID: 21092187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial correction of the alpha-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors.
    Przybylska M; Wu IH; Zhao H; Ziegler RJ; Tousignant JD; Desnick RJ; Scheule RK; Cheng SH; Yew NS
    J Gene Med; 2004 Jan; 6(1):85-92. PubMed ID: 14716680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy.
    Desnick RJ; Banikazemi M
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S172-85. PubMed ID: 17373219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of multiple angiomas without any angiokeratomas in a female heterozygote with Fabry disease.
    Mirceva V; Hein R; Ring J; Möhrenschlager M
    Australas J Dermatol; 2010 Feb; 51(1):36-8. PubMed ID: 20148840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ocular findings in Fabry's disease].
    Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J
    Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry.
    Kitagawa T; Ishige N; Suzuki K; Owada M; Ohashi T; Kobayashi M; Eto Y; Tanaka A; Mills K; Winchester B; Keutzer J
    Mol Genet Metab; 2005 Jul; 85(3):196-202. PubMed ID: 15979031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of Fabry's disease with chronic renal failure].
    Suzuki T; Fujino T; Sugasawa M; Kohara Y; Toyama K; Sato T; Yasuda T; Sugiyama M; Maeba T; Owada S; Ishida M
    Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):448-53. PubMed ID: 10441995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of acroparesthesias, asthenia and fever. A new mutation in Fabry's disease].
    Cruz M; Araújo F; Nogueira D; Neves F
    Acta Reumatol Port; 2011; 36(4):399-403. PubMed ID: 22472932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.
    Torvin Møller A; Winther Bach F; Feldt-Rasmussen U; Rasmussen A; Hasholt L; Lan H; Sommer C; Kølvraa S; Ballegaard M; Staehelin Jensen T
    Pain; 2009 Sep; 145(1-2):237-45. PubMed ID: 19665302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular genetics of inherited metabolic diseases--its application to the investigation of pathogenesis and the diagnosis of Fabry disease].
    Sakuraba H
    Rinsho Byori; 1994 Jun; 42(6):628-35. PubMed ID: 7914243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry.
    Hopkin RJ; Bissler J; Banikazemi M; Clarke L; Eng CM; Germain DP; Lemay R; Tylki-Szymanska A; Wilcox WR
    Pediatr Res; 2008 Nov; 64(5):550-5. PubMed ID: 18596579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Description of a new mutation in a female patient with Fabry disease].
    Correia E; Vidinha J; Rodrigues B; Santos L; Moreira D; Garrido J; Clara Sá Miranda M; Cabral C; Santos O
    Rev Port Cardiol; 2011 Oct; 30(10):789-93. PubMed ID: 22118130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.